Neutralizing Antibody Response to SARS Coronavirus, Figure 4

Volume 11, Number 3, March 2005

Longitudinally Profiling Neutralizing Antibody Response to SARS Coronavirus with Pseudotypes

Nigel J. Temperton,* Paul K. Chan,† Graham Simmons,‡ Maria C. Zambon,§ Richard S. Tedder,* Yasuhiro Takeuchi,* and Robin A. Weiss*
*University College London, London, United Kingdom; †Prince of Wales Hospital, Shatin, New Territories, Hong Kong Special Administrative Region, People's Republic of China; ‡University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA; and §Health Protection Agency Central Public Health Laboratory, London, United Kingdom


	Back to article
	Figure 4. Neutralizing antibodies to severe acute respiratory syndrome–associated coronavirus spike protein in sequential blood samples from 4 representative patients. Lines represent profiles of individual patients. Filled black symbols represent geometric mean titers at individual time points. IC₉₀, 90% inhibitory concentration.

	EID Home \| Top of Page \| Ahead-of-Print \| Past Issues \| Suggested Citation \| EID Search \| Contact Us \| Accessibility \| Privacy Policy Notice \| CDC Home \| CDC Search \| Health Topics A-Z

	This page last reviewed February 14, 2005

	Emerging Infectious Diseases Journal National Center for Infectious Diseases Centers for Disease Control and Prevention